Time for a second opinion on health care stocks?

The health care sector has underperformed against key sectors and the broader market over the last year. Stocks have underperformed due to political risks, with President Donald Trump appointing Robert F. Kennedy Jr, a pharma critic, as Health Secretary; industry-wide tariff threats and price controls are also creating concerns. High interest rates have negatively impacted attitudes towards growth stocks, with declines in stocks further shaking investors’ confidence. However, they are currently the most attractive they’ve been for a while, becoming cheaper but expecting positive results over...